Method
Level · gp.fundamentals.debt_to_revenue
Raw value 87.11% · OPTIONAL
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTAGENUS INC's latest supported as-filed period reports revenue of $34.5M, 34.4% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 87.11% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.00% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -90.38% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 34.36% · CORE
Level · gp.fundamentals.gross_margin
Raw value 100.00% · CORE
Level · gp.fundamentals.operating_margin
Raw value 32.72% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +96.5% from the comparable as-filed period.
Debt changed -11.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Net income changed +98.1% from the comparable as-filed period.
Operating income changed +167.6% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
AGEN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-355559SEC ↗8-KAug 13, 2026Period Aug 10, 20260001193125-26-347518SEC ↗4Aug 12, 2026Period Aug 10, 20260001193125-26-347517SEC ↗8-KAug 11, 2026Period Aug 5, 20260001193125-26-344783SEC ↗4Aug 11, 2026Period Aug 5, 20260001193125-26-344617SEC ↗4Aug 11, 2026Period Aug 5, 20260001193125-26-344599SEC ↗10-QAug 7, 2026Period Jun 30, 20260001193125-26-340363SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 10, 2026Filed Aug 12, 2026 | ARMEN GARO HSee Remarks | Grant Or AwardDirect | 1,971,500 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 42.76% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 9.44% · OPTIONAL
Operating margin changed +9776 basis points from the comparable as-filed period.
Research & development changed -44.7% from the comparable as-filed period.
Revenue changed +34.4% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-340007